The biotech firm's shares were trading up 7% by mid-session, their biggest intraday gain since March 2020

The company will "explore partnerships in providing accurate, affordable and accessible cancer early detection to the Hong Kong and Greater Bay Area communities"

The recommendation, which sent Innovent shares down, raises concerns for other Chinese drugmakers seeking to bring products to the US market

Sintilimab, made by Suzhou-based Innovent and US drugmaker Eli Lilly, has been developed and commercialised under a global agreement

Anthony Fauci said US was leaving a "full-blown" pandemic behind, while drugmaker Pfizer forecast more than $50 billion in 2022 sales

Shares of WuXi Biologics plunge 25% after Commerce Dept adds 33 Chinese entities to its 'unverified list', which requires exporters to go through more procedures before shipping goods

The company said governments and private customers can instantly verify the provenance and authenticity of vaccines and other drugs

The action follows November's regulatory guidelines to stamp out monopolies in active pharmaceutical ingredients

  The US has banned imports from YTY Industry Holdings, a Malaysian manufacturer of personal protective equipment (PPE), over suspected...

Canada detected a case of bovine spongiform encephalopathy in December 2021 on an Alberta farm, the country's first known BSE case in six years

Takeshi Kasai is accused of presiding over a "toxic atmosphere" at the regional office with a culture of "systemic bullying and ridiculing"

JV is devoted to the development and production of biosimilars, compounds close in structure to a biologic, which is made from proteins